Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Harmonic | HLIT | Nov 1, 2024 | 10.96 | -1.17 |
Harmony Biosciences | HRMY | Nov 1, 2024 | 33.08 | +2.96 |
Harmony Gold Mining ADR | HMY | Nov 1, 2024 | 10.57 | -2.49 |
Harrow | HROW | Nov 1, 2024 | 45.64 | +1.29 |
Hartford Financial Services G Pref | HIG-G | Nov 1, 2024 | 25.07 | -0.40 |
Hartford Financial Services Group | HIG | Nov 1, 2024 | 110.09 | -0.32 |
Hartford Multifactor Developed Markets (ex-US) ETF | RODM | Nov 1, 2024 | 29.43 | +0.17 |
Harvard Bioscience | HBIO | Nov 1, 2024 | 2.40 | +2.13 |
Hasbro | HAS | Nov 1, 2024 | 65.82 | +0.29 |
Haverty Furniture Companies | HVT | Nov 1, 2024 | 21.96 | -0.86 |
Haverty Furniture Companies | HVT-A | Nov 1, 2024 | 22.42 | 0.00 |
Hawaiian Electric Industries | HE | Nov 1, 2024 | 10.22 | -0.49 |
Hawaiian Holdings | HA | Nov 1, 2024 | 18.00 | 0.00 |
Hawkins | HWKN | Nov 1, 2024 | 106.40 | -0.47 |
Hawthorn Bancshares | HWBK | Nov 1, 2024 | 28.08 | -1.27 |
Haymaker Acquisition 4 | HYAC | Nov 1, 2024 | 10.68 | 0.00 |
Haynes International | HAYN | Nov 1, 2024 | 60.71 | +0.58 |
Hayward | HAYW | Nov 1, 2024 | 16.15 | -0.68 |
HBT Financial | HBT | Nov 1, 2024 | 21.45 | +0.42 |
HCA Healthcare | HCA | Nov 1, 2024 | 357.19 | -0.43 |
HCI Group | HCI | Nov 1, 2024 | 112.02 | -1.14 |
HCM II Acquisition | HOND | Nov 1, 2024 | 9.99 | 0.00 |
HCM II Acquisition | HONDU | Nov 1, 2024 | 10.02 | 0.00 |
HCW Biologics | HCWB | Nov 1, 2024 | 0.43 | -0.23 |
HDFC Bank ADR | HDB | Nov 1, 2024 | 63.20 | +0.27 |
Health Catalyst | HCAT | Nov 1, 2024 | 7.70 | -0.90 |
Healthcare AI Acquisition A | HAIA | Nov 1, 2024 | 11.50 | -0.17 |
Healthcare Alphadex First Trust | FXH | Nov 1, 2024 | 108.27 | +1.14 |
Healthcare Bull 3X Direxion | CURE | Nov 1, 2024 | 116.01 | +1.58 |
Healthcare ETF Vanguard | VHT | Nov 1, 2024 | 271.72 | +0.76 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.